ABEO
Abeona Therapeutics Inc.
Approval
Confirmed
ZEVASKYN
recessive dystrophic epidermolysis bullosa (RDEB)
478d ago
~ Apr 30, 2025
SEC 8-K
verified 2mo ago
Countdown card →